Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Wrong age; administered the wrong vaccine to a patient; Inappropriate schedule of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis. Previously administered products included Vaxelis (received first dose of Vaxelis on 11-OCT-2023), Vaxelis (received second dose of Vaxelis on 21-NOV-2023) and Vaxelis (received third dose of Vaxelis on 22-JAN-2024). On 05-MAR-2025, the patient received Kinrix. On 05-MAR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Wrong age), wrong vaccine administered (Verbatim: administered the wrong vaccine to a patient) and inappropriate schedule of vaccine administered (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the inappropriate age at vaccine administration, wrong vaccine administered and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-MAR-2025 The other health professional reported that they administered the wrong vaccine to a patient which led to wrong vaccine administered. Kinrix was given and patient was 19 months old which led to inappropriate age at vaccine administration. The patient got 3 prior Vaxelis doses which led to inappropriate schedule of vaccine administered.